* Aethlon Medical Inc AEMD.OQ reported a quarterly
adjusted loss
of 12 cents per share for the quarter ended in December. The
mean expectation of three analysts for the quarter was for a
loss of 8 cents per share.
* Reported revenue was zero; analysts expected $3.17
million.
* Aethlon Medical Inc's reported EPS for the quarter was a
loss
of 12 cents.
* The mean earnings estimate of analysts had risen by
about 62.8%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Aethlon Medical Inc shares had risen by 92.4% this
quarter.
* The company reported a quarterly loss of $2.85 million.
* Wall Street's median 12-month price target for Aethlon
Medical
Inc is $8.50
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data February
13 at 10:16 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2022 -0.08 -0.12 Missed
Sep. 30 2022 -0.21 -0.18 Beat
Jun. 30 2022 -0.22 -0.19 Beat
Mar. 31 2022 -0.14 -0.26 Missed